Your browser doesn't support javascript.
loading
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease Management.
Sacco, Matteo; Gandaglia, Giorgio; Aas, Kirsti; Ceci, Francesco; Chiu, Peter; Fankhauser, Christian D; Fournier, Georges; Heiddeger, Isabel; Kasivisvanathan, Veeru; Kesch, Claudia; Maggi, Martina; Martini, Alberto; Olivier, Jonathan; Ploussard, Guillaume; Preisser, Felix; Puche-Sanz, Ignacio; Rajwa, Pawel; Soeterik, Timo; Thibault, Constance; Valerio, Massimo; van den Bergh, Roderick C N; Zattoni, Fabio; Rivas, Juan Gómez; Moschini, Marco; Gillessen, Silke; Bossi, Alberto; Gontero, Paolo; Marra, Giancarlo.
Afiliación
  • Sacco M; Department of Urology, San Giovanni Battista Hospital, University of Torino, Torino, Italy.
  • Gandaglia G; Unit of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Aas K; Department of Surgery, Vestre Viken Hospital Trust, Bærum Hospital, Drammen, Norway.
  • Ceci F; Division of Nuclear Medicine, IEO European Institute of Oncology, Milan, Italy.
  • Chiu P; SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
  • Fankhauser CD; Department of Urology, University Hospital Zürich, University of Zürich, Zurich, Switzerland.
  • Fournier G; AFU, Association Francaise d'Urologie.
  • Heiddeger I; Department of Urology, Medical University Innsbruck, Innsbruck, Austria.
  • Kasivisvanathan V; Division of Surgery and Interventional Science, University College London, London, UK.
  • Kesch C; Department of Urology, University Hospital Essen, Essen, Germany.
  • Maggi M; Department of Maternal Infant and Urologic Sciences, Policlinico Umberto I Hospital, "Sapienza" University of Rome, Rome, Italy.
  • Martini A; Unit of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Olivier J; Department of Urology, Lille University Hospital, Lille, France.
  • Ploussard G; AFU, Association Francaise d'Urologie.
  • Preisser F; Department of Urology, University Hospital Frankfurt, Frankfurt, Germany.
  • Puche-Sanz I; Department of Urology, Bio-Health Research Institute, Hospital Universitario Virgen de las Nieves, University of Granada, Granada, Spain.
  • Rajwa P; Department of Urology, Medical University of Silesia, Zabrze, Poland.
  • Soeterik T; Department of Urology, St. Antonius Hospital, Utrecht, The Netherlands.
  • Thibault C; Department of Medical Oncology, European Georges Pompidou Hospital, Assistance Publique des Hôpitaux de Paris, Paris Descartes University, Paris, France.
  • Valerio M; Department of Urology, CHUV Lausanne, Lausanne, Switzerland.
  • van den Bergh RCN; Department of Urology, St. Antonius Hospital, Utrecht, The Netherlands.
  • Zattoni F; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Rivas JG; Department of Urology, Hospital Clínico San Carlos, Madrid, Spain.
  • Moschini M; Unit of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Gillessen S; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland.
  • Bossi A; Department of Radiotherapy, Gustave Roussy Cancer Institute, Villejuif, France.
  • Gontero P; Department of Urology, San Giovanni Battista Hospital, University of Torino, Torino, Italy.
  • Marra G; Department of Urology, San Giovanni Battista Hospital, University of Torino, Torino, Italy. Electronic address: drgiancarlomarra@gmail.com.
Clin Genitourin Cancer ; 21(3): 416.e1-416.e10, 2023 06.
Article en En | MEDLINE | ID: mdl-36609130
ABSTRACT

INTRODUCTION:

The urological community's opinion over the management of men being found with pathologically positive nodes (pN+) following radical prostatectomy (RP) performed with curative intent after preoperative negative conventional staging (cN0M0) has never been assessed. This remains crucial, especially considering the advent of novel imaging modalities. Our aim was to investigate the current opinion on management of pN+ cN0M0 prostate cancer (PCa) in the European urological community.

METHODS:

Following validation, a 31-item survey, complying with the Cherries checklist, was distributed using a web link from December 2021 to April 2022 to 10 urological societies mailing list. Social media (Twitter, Facebook) were also used.

RESULTS:

We received 253 replies. The majority were Urologists (96.8%), younger than 60 (90.5%); 5.2% did not have access to PET-scans; 78.9% believed pN+ is a multifaceted category; 10-years CSS was marked as 71 to 95% by 17.5%. Gold standard management was stated not being ADT by 80.8% and being RT±ADT by 52.3%. Early sRT±ADT was considered an option vs. aRT±ADT by 72.4%. In case of BCR 71% would perform and decide management based on PSMA-PET whilst 3.7% would not perform PSMA-PET. pN+ management is still unclear for 77.1%. On multivariate analysis PSMA-PET availability related to a lower and higher likelihood of considering aRT±ADT as standard and of considering early salvage versus aRT respectively (P < .05).

CONCLUSIONS:

The Urological community has an acceptable awareness of pN+ disease and management, although it may overestimate disease aggressiveness. The majority consider pN+ PCa as a multifaceted category and rely on a risk-adapted approach. Expectant compared to immediate upfront management and new imaging modalities are increasingly considered.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioisótopos de Galio Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioisótopos de Galio Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article